Roles and responsibilities of a medical geneticist

Familial Cancer

Volumn 7, Issue 1, 2008, Pages 5-14

  Rubinstein, Wendy S ^a,b  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BRCA1 genes; BRCA2 genes; Differential diagnosis; Duty to recontact; Evidence based medicine; Genetic screening; Genetic services; Medical ethics; Medical genetics; Prophylactic surgery; Risk assessment; Stomach neoplasms

Indexed keywords

BREAST CANCER; CANCER RISK; CLINICAL PRACTICE; CONFERENCE PAPER; DECISION MAKING; DIFFERENTIAL DIAGNOSIS; DUTY TO RECONTACT; HIGH RISK POPULATION; HUMAN; MEDICAL ETHICS; MEDICAL GENETICS; MEDICAL PRACTICE; MEDICAL SPECIALIST; ONCOGENE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER; TUMOR SUPPRESSOR GENE; AGED; ARTICLE; BREAST TUMOR; CASE REPORT; ETHICS; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FEMALE; GENETIC COUNSELING; GENETICS; PEDIGREE; PHYSICIAN ATTITUDE; PSYCHOLOGICAL ASPECT; SOCIAL BEHAVIOR; STOMACH TUMOR; SURGERY; WRITING;

AGED; BREAST NEOPLASMS; CORRESPONDENCE AS TOPIC; DIAGNOSIS, DIFFERENTIAL; DUTY TO RECONTACT; EVIDENCE-BASED MEDICINE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETICS, MEDICAL; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; PHYSICIAN'S ROLE; SOCIAL RESPONSIBILITY; STOMACH NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE;

EID: 46449132435     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9148-6     Document Type: Conference Paper

References (16)

1. SA Narod WD Foulkes 2004 BRCA1 and BRCA2: 1994 and beyond Nat Rev Cancer 4 9 665 676
2. HT Lynch W Grady G Suriano D Huntsman 2005 Gastric cancer: new genetic developments J Surg Oncol 90 3 114 133
3. G Parmigiani D Berry O Aguilar 1998 Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 Am J Hum Genet 62 1 145 158
4. MS Brose TR Rebbeck KA Calzone JE Stopfer KL Nathanson BL Weber 2002 Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 18 1365 1372
5. D Thompson DF Easton 2002 Cancer Incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 18 1358 1365
6. O Johannsson N Loman T Moller U Kristoffersson A Borg H Olsson 1999 Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers Eur J Cancer 35 8 1248 1257
7. DL Sackett WM Rosenberg JA Gray RB Haynes WS Richardson 1996 Evidence based medicine: what it is and what it isn't Bmj 312 7023 71 72
8. A Liede K Metcalfe K Offit 1998 A family with three germline mutations in BRCA1 and BRCA2 Clin Genet 54 3 215 218
9. TS Frank AM Deffenbaugh JE Reid 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals J Clin Oncol 20 6 1480 1490
10. ND Kauff P Perez-Segura ME Robson 2002 Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families J Med Genet 39 8 611 614
11. WS Rubinstein SM O'Neill JA Peters LJ Rittmeyer MP Stadler 2002 Mathematical modeling for breast cancer risk assessment. State of the art and role in medicine Oncology (Huntingt) 16 8 1082 1094
12. MD Schwartz C Lerman B Brogan 2004 Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients J Clin Oncol 22 10 1823 1829
13. JL Fitzpatrick C Hahn T Costa MJ Huggins 1999 The duty to recontact: attitudes of genetics service providers Am J Hum Genet 64 3 852 860
14. WS Rubinstein HK Roy 2005 Practicing medicine at the front lines of the genomic revolution Arch Intern Med 165 16 1815 1817
15. GY Locker K Kaul DS Weinberg 2006 The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features Cancer Genet Cytogenet 169 1 33 38
16. T Walsh S Casadei KH Coats 2006 Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 12 1379 1388